nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—Ethynodiol—ESR1—atherosclerosis	0.00708	0.701	CrCbGaD
Cyproterone acetate—Abnormal vision—Niacin—atherosclerosis	0.00329	0.00419	CcSEcCtD
Cyproterone acetate—Pancreatitis—Rosuvastatin—atherosclerosis	0.00319	0.00406	CcSEcCtD
Cyproterone acetate—Diabetes mellitus—Niacin—atherosclerosis	0.00315	0.00401	CcSEcCtD
Cyproterone acetate—Sleep disorder—Pravastatin—atherosclerosis	0.00312	0.00397	CcSEcCtD
Cyproterone acetate—Eczema—Niacin—atherosclerosis	0.00305	0.00388	CcSEcCtD
Cyproterone acetate—Medroxyprogesterone Acetate—ESR1—atherosclerosis	0.00301	0.298	CrCbGaD
Cyproterone acetate—Hepatic failure—Pravastatin—atherosclerosis	0.003	0.00382	CcSEcCtD
Cyproterone acetate—Haemolytic anaemia—Pravastatin—atherosclerosis	0.00299	0.00381	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Ezetimibe—atherosclerosis	0.00289	0.00368	CcSEcCtD
Cyproterone acetate—Hot flush—Pravastatin—atherosclerosis	0.00288	0.00367	CcSEcCtD
Cyproterone acetate—Menopausal symptoms—Pravastatin—atherosclerosis	0.00286	0.00364	CcSEcCtD
Cyproterone acetate—Jaundice—Rosuvastatin—atherosclerosis	0.00283	0.0036	CcSEcCtD
Cyproterone acetate—Breast disorder—Ezetimibe—atherosclerosis	0.00283	0.0036	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.00282	0.00359	CcSEcCtD
Cyproterone acetate—Haematuria—Rosuvastatin—atherosclerosis	0.00277	0.00352	CcSEcCtD
Cyproterone acetate—Muscular weakness—Ezetimibe—atherosclerosis	0.00276	0.00352	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.00276	0.00352	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00274	0.00349	CcSEcCtD
Cyproterone acetate—Disturbance in sexual arousal—Niacin—atherosclerosis	0.00272	0.00346	CcSEcCtD
Cyproterone acetate—Pancreatitis—Lovastatin—atherosclerosis	0.0027	0.00344	CcSEcCtD
Cyproterone acetate—Migraine—Niacin—atherosclerosis	0.0027	0.00344	CcSEcCtD
Cyproterone acetate—Affect lability—Pravastatin—atherosclerosis	0.00265	0.00338	CcSEcCtD
Cyproterone acetate—Pancreatitis—Ezetimibe—atherosclerosis	0.00265	0.00338	CcSEcCtD
Cyproterone acetate—Muscular weakness—Simvastatin—atherosclerosis	0.00263	0.00335	CcSEcCtD
Cyproterone acetate—Hepatitis—Rosuvastatin—atherosclerosis	0.0026	0.00332	CcSEcCtD
Cyproterone acetate—Mood swings—Pravastatin—atherosclerosis	0.00256	0.00326	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Lovastatin—atherosclerosis	0.00254	0.00323	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Niacin—atherosclerosis	0.00253	0.00322	CcSEcCtD
Cyproterone acetate—Pancreatitis—Simvastatin—atherosclerosis	0.00253	0.00322	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Lovastatin—atherosclerosis	0.00252	0.00321	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00249	0.00317	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Pravastatin—atherosclerosis	0.00249	0.00317	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.00247	0.00314	CcSEcCtD
Cyproterone acetate—Muscular weakness—Niacin—atherosclerosis	0.00242	0.00308	CcSEcCtD
Cyproterone acetate—Muscular weakness—Pravastatin—atherosclerosis	0.00238	0.00303	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00238	0.00303	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Simvastatin—atherosclerosis	0.00237	0.00303	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Simvastatin—atherosclerosis	0.00235	0.003	CcSEcCtD
Cyproterone acetate—Jaundice—Ezetimibe—atherosclerosis	0.00235	0.00299	CcSEcCtD
Cyproterone acetate—Pancreatitis—Pravastatin—atherosclerosis	0.00229	0.00291	CcSEcCtD
Cyproterone acetate—Mental disorder—Rosuvastatin—atherosclerosis	0.00228	0.00291	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00228	0.0029	CcSEcCtD
Cyproterone acetate—Sweating increased—Pravastatin—atherosclerosis	0.00227	0.00289	CcSEcCtD
Cyproterone acetate—Jaundice—Simvastatin—atherosclerosis	0.00224	0.00286	CcSEcCtD
Cyproterone acetate—Hepatitis—Lovastatin—atherosclerosis	0.00221	0.00281	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Niacin—atherosclerosis	0.00218	0.00278	CcSEcCtD
Cyproterone acetate—Hepatitis—Ezetimibe—atherosclerosis	0.00216	0.00276	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Pravastatin—atherosclerosis	0.00215	0.00274	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Pravastatin—atherosclerosis	0.00213	0.00271	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00213	0.00271	CcSEcCtD
Cyproterone acetate—Weight increased—Pravastatin—atherosclerosis	0.00212	0.0027	CcSEcCtD
Cyproterone acetate—Weight decreased—Pravastatin—atherosclerosis	0.00211	0.00269	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Lovastatin—atherosclerosis	0.00209	0.00266	CcSEcCtD
Cyproterone acetate—Hepatitis—Simvastatin—atherosclerosis	0.00206	0.00263	CcSEcCtD
Cyproterone acetate—Jaundice—Niacin—atherosclerosis	0.00206	0.00262	CcSEcCtD
Cyproterone acetate—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00205	0.00261	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Ezetimibe—atherosclerosis	0.00205	0.00261	CcSEcCtD
Cyproterone acetate—Myocardial infarction—Pravastatin—atherosclerosis	0.00204	0.0026	CcSEcCtD
Cyproterone acetate—Jaundice—Pravastatin—atherosclerosis	0.00203	0.00258	CcSEcCtD
Cyproterone acetate—Sweating—Niacin—atherosclerosis	0.00202	0.00258	CcSEcCtD
Cyproterone acetate—Chills—Lovastatin—atherosclerosis	0.00198	0.00252	CcSEcCtD
Cyproterone acetate—Cough—Rosuvastatin—atherosclerosis	0.00198	0.00252	CcSEcCtD
Cyproterone acetate—Angiopathy—Ezetimibe—atherosclerosis	0.00196	0.0025	CcSEcCtD
Cyproterone acetate—Immune system disorder—Ezetimibe—atherosclerosis	0.00195	0.00249	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Simvastatin—atherosclerosis	0.00195	0.00249	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00195	0.00248	CcSEcCtD
Cyproterone acetate—Alopecia—Lovastatin—atherosclerosis	0.00195	0.00248	CcSEcCtD
Cyproterone acetate—Alopecia—Ezetimibe—atherosclerosis	0.00191	0.00244	CcSEcCtD
Cyproterone acetate—Haemoglobin—Niacin—atherosclerosis	0.0019	0.00243	CcSEcCtD
Cyproterone acetate—Mental disorder—Ezetimibe—atherosclerosis	0.0019	0.00242	CcSEcCtD
Cyproterone acetate—Hepatitis—Niacin—atherosclerosis	0.0019	0.00241	CcSEcCtD
Cyproterone acetate—Haemorrhage—Niacin—atherosclerosis	0.0019	0.00241	CcSEcCtD
Cyproterone acetate—Malnutrition—Ezetimibe—atherosclerosis	0.00188	0.0024	CcSEcCtD
Cyproterone acetate—Hepatitis—Pravastatin—atherosclerosis	0.00187	0.00238	CcSEcCtD
Cyproterone acetate—Chills—Simvastatin—atherosclerosis	0.00185	0.00236	CcSEcCtD
Cyproterone acetate—Visual impairment—Niacin—atherosclerosis	0.00183	0.00233	CcSEcCtD
Cyproterone acetate—Alopecia—Simvastatin—atherosclerosis	0.00182	0.00232	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00181	0.00231	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00181	0.00231	CcSEcCtD
Cyproterone acetate—Mental disorder—Simvastatin—atherosclerosis	0.00181	0.0023	CcSEcCtD
Cyproterone acetate—Visual impairment—Pravastatin—atherosclerosis	0.0018	0.00229	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Lovastatin—atherosclerosis	0.00178	0.00227	CcSEcCtD
Cyproterone acetate—Eye disorder—Niacin—atherosclerosis	0.00177	0.00226	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Pravastatin—atherosclerosis	0.00176	0.00225	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00175	0.00223	CcSEcCtD
Cyproterone acetate—Anaemia—Ezetimibe—atherosclerosis	0.00174	0.00222	CcSEcCtD
Cyproterone acetate—Malaise—Lovastatin—atherosclerosis	0.00173	0.00221	CcSEcCtD
Cyproterone acetate—Angiopathy—Niacin—atherosclerosis	0.00172	0.00219	CcSEcCtD
Cyproterone acetate—Leukopenia—Lovastatin—atherosclerosis	0.00172	0.00219	CcSEcCtD
Cyproterone acetate—Chills—Niacin—atherosclerosis	0.0017	0.00217	CcSEcCtD
Cyproterone acetate—Malaise—Ezetimibe—atherosclerosis	0.0017	0.00216	CcSEcCtD
Cyproterone acetate—Alopecia—Niacin—atherosclerosis	0.00167	0.00213	CcSEcCtD
Cyproterone acetate—Chills—Pravastatin—atherosclerosis	0.00167	0.00213	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Simvastatin—atherosclerosis	0.00167	0.00212	CcSEcCtD
Cyproterone acetate—Anaemia—Simvastatin—atherosclerosis	0.00166	0.00212	CcSEcCtD
Cyproterone acetate—Malnutrition—Niacin—atherosclerosis	0.00165	0.0021	CcSEcCtD
Cyproterone acetate—Alopecia—Pravastatin—atherosclerosis	0.00165	0.0021	CcSEcCtD
Cyproterone acetate—Cough—Ezetimibe—atherosclerosis	0.00164	0.00209	CcSEcCtD
Cyproterone acetate—Dyspepsia—Rosuvastatin—atherosclerosis	0.00163	0.00207	CcSEcCtD
Cyproterone acetate—Malaise—Simvastatin—atherosclerosis	0.00162	0.00206	CcSEcCtD
Cyproterone acetate—Tension—Niacin—atherosclerosis	0.00162	0.00206	CcSEcCtD
Cyproterone acetate—Discomfort—Lovastatin—atherosclerosis	0.00162	0.00206	CcSEcCtD
Cyproterone acetate—Leukopenia—Simvastatin—atherosclerosis	0.00161	0.00205	CcSEcCtD
Cyproterone acetate—Tension—Pravastatin—atherosclerosis	0.00159	0.00203	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00159	0.00203	CcSEcCtD
Cyproterone acetate—Discomfort—Ezetimibe—atherosclerosis	0.00158	0.00202	CcSEcCtD
Cyproterone acetate—Constipation—Rosuvastatin—atherosclerosis	0.00158	0.00202	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Lovastatin—atherosclerosis	0.00153	0.00196	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00152	0.00194	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00151	0.00193	CcSEcCtD
Cyproterone acetate—Discomfort—Simvastatin—atherosclerosis	0.00151	0.00193	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Ezetimibe—atherosclerosis	0.00151	0.00192	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Pravastatin—atherosclerosis	0.00151	0.00192	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00151	0.00192	CcSEcCtD
Cyproterone acetate—Anaemia—Pravastatin—atherosclerosis	0.0015	0.00191	CcSEcCtD
Cyproterone acetate—Anorexia—Lovastatin—atherosclerosis	0.00149	0.0019	CcSEcCtD
Cyproterone acetate—Skin disorder—Ezetimibe—atherosclerosis	0.00149	0.0019	CcSEcCtD
Cyproterone acetate—Syncope—Niacin—atherosclerosis	0.00148	0.00188	CcSEcCtD
Cyproterone acetate—Leukopenia—Niacin—atherosclerosis	0.00148	0.00188	CcSEcCtD
Cyproterone acetate—Urticaria—Rosuvastatin—atherosclerosis	0.00147	0.00187	CcSEcCtD
Cyproterone acetate—Oedema—Simvastatin—atherosclerosis	0.00147	0.00187	CcSEcCtD
Cyproterone acetate—Malaise—Pravastatin—atherosclerosis	0.00146	0.00187	CcSEcCtD
Cyproterone acetate—Abdominal pain—Rosuvastatin—atherosclerosis	0.00146	0.00186	CcSEcCtD
Cyproterone acetate—Leukopenia—Pravastatin—atherosclerosis	0.00145	0.00185	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Niacin—atherosclerosis	0.00145	0.00185	CcSEcCtD
Cyproterone acetate—Cough—Niacin—atherosclerosis	0.00144	0.00183	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Simvastatin—atherosclerosis	0.00144	0.00183	CcSEcCtD
Cyproterone acetate—Cough—Pravastatin—atherosclerosis	0.00142	0.00181	CcSEcCtD
Cyproterone acetate—Anorexia—Simvastatin—atherosclerosis	0.0014	0.00178	CcSEcCtD
Cyproterone acetate—Dyspnoea—Lovastatin—atherosclerosis	0.0014	0.00178	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00139	0.00178	CcSEcCtD
Cyproterone acetate—Dyspepsia—Lovastatin—atherosclerosis	0.00138	0.00176	CcSEcCtD
Cyproterone acetate—Dyspnoea—Ezetimibe—atherosclerosis	0.00137	0.00175	CcSEcCtD
Cyproterone acetate—Discomfort—Pravastatin—atherosclerosis	0.00137	0.00174	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00136	0.00174	CcSEcCtD
Cyproterone acetate—Decreased appetite—Lovastatin—atherosclerosis	0.00136	0.00174	CcSEcCtD
Cyproterone acetate—Dyspepsia—Ezetimibe—atherosclerosis	0.00135	0.00172	CcSEcCtD
Cyproterone acetate—Fatigue—Lovastatin—atherosclerosis	0.00135	0.00172	CcSEcCtD
Cyproterone acetate—Oedema—Niacin—atherosclerosis	0.00135	0.00172	CcSEcCtD
Cyproterone acetate—Constipation—Lovastatin—atherosclerosis	0.00134	0.00171	CcSEcCtD
Cyproterone acetate—Decreased appetite—Ezetimibe—atherosclerosis	0.00134	0.0017	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00133	0.00169	CcSEcCtD
Cyproterone acetate—Asthenia—Rosuvastatin—atherosclerosis	0.00133	0.00169	CcSEcCtD
Cyproterone acetate—Oedema—Pravastatin—atherosclerosis	0.00133	0.00169	CcSEcCtD
Cyproterone acetate—Fatigue—Ezetimibe—atherosclerosis	0.00133	0.00169	CcSEcCtD
Cyproterone acetate—Shock—Niacin—atherosclerosis	0.00132	0.00169	CcSEcCtD
Cyproterone acetate—Constipation—Ezetimibe—atherosclerosis	0.00131	0.00168	CcSEcCtD
Cyproterone acetate—Tachycardia—Niacin—atherosclerosis	0.00131	0.00167	CcSEcCtD
Cyproterone acetate—Pruritus—Rosuvastatin—atherosclerosis	0.00131	0.00167	CcSEcCtD
Cyproterone acetate—Skin disorder—Niacin—atherosclerosis	0.00131	0.00167	CcSEcCtD
Cyproterone acetate—Dyspnoea—Simvastatin—atherosclerosis	0.00131	0.00167	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Niacin—atherosclerosis	0.0013	0.00166	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Pravastatin—atherosclerosis	0.0013	0.00165	CcSEcCtD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP7A1—atherosclerosis	0.00129	0.0064	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—AHR—atherosclerosis	0.00129	0.0064	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Lovastatin—atherosclerosis	0.00129	0.00165	CcSEcCtD
Cyproterone acetate—Dyspepsia—Simvastatin—atherosclerosis	0.00129	0.00164	CcSEcCtD
Cyproterone acetate—Anorexia—Niacin—atherosclerosis	0.00128	0.00164	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00128	0.00163	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Pravastatin—atherosclerosis	0.00128	0.00163	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—SIRT1—atherosclerosis	0.00128	0.00632	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Simvastatin—atherosclerosis	0.00127	0.00162	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Ezetimibe—atherosclerosis	0.00127	0.00161	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00127	0.00161	CcSEcCtD
Cyproterone acetate—Diarrhoea—Rosuvastatin—atherosclerosis	0.00127	0.00161	CcSEcCtD
Cyproterone acetate—Fatigue—Simvastatin—atherosclerosis	0.00126	0.00161	CcSEcCtD
Cyproterone acetate—Anorexia—Pravastatin—atherosclerosis	0.00126	0.00161	CcSEcCtD
Cyproterone acetate—Hypotension—Niacin—atherosclerosis	0.00126	0.0016	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00126	0.0016	CcSEcCtD
Cyproterone acetate—NR3C1—Nuclear Receptors—ESR1—atherosclerosis	0.00126	0.00621	CbGpPWpGaD
Cyproterone acetate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—atherosclerosis	0.00126	0.00621	CbGpPWpGaD
Cyproterone acetate—Constipation—Simvastatin—atherosclerosis	0.00125	0.0016	CcSEcCtD
Cyproterone acetate—Urticaria—Lovastatin—atherosclerosis	0.00125	0.00159	CcSEcCtD
Cyproterone acetate—Body temperature increased—Lovastatin—atherosclerosis	0.00124	0.00158	CcSEcCtD
Cyproterone acetate—Abdominal pain—Lovastatin—atherosclerosis	0.00124	0.00158	CcSEcCtD
Cyproterone acetate—Dizziness—Rosuvastatin—atherosclerosis	0.00122	0.00156	CcSEcCtD
Cyproterone acetate—Urticaria—Ezetimibe—atherosclerosis	0.00122	0.00156	CcSEcCtD
Cyproterone acetate—Abdominal pain—Ezetimibe—atherosclerosis	0.00122	0.00155	CcSEcCtD
Cyproterone acetate—Body temperature increased—Ezetimibe—atherosclerosis	0.00122	0.00155	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP27A1—atherosclerosis	0.00121	0.006	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Simvastatin—atherosclerosis	0.00121	0.00154	CcSEcCtD
Cyproterone acetate—Dyspnoea—Niacin—atherosclerosis	0.0012	0.00153	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Simvastatin—atherosclerosis	0.0012	0.00153	CcSEcCtD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP27A1—atherosclerosis	0.0012	0.00592	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—PPARG—atherosclerosis	0.00119	0.0059	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—atherosclerosis	0.00119	0.00589	CbGpPWpGaD
Cyproterone acetate—Dyspepsia—Niacin—atherosclerosis	0.00119	0.00151	CcSEcCtD
Cyproterone acetate—Dyspnoea—Pravastatin—atherosclerosis	0.00118	0.00151	CcSEcCtD
Cyproterone acetate—Decreased appetite—Niacin—atherosclerosis	0.00117	0.00149	CcSEcCtD
Cyproterone acetate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—atherosclerosis	0.00117	0.00578	CbGpPWpGaD
Cyproterone acetate—Dyspepsia—Pravastatin—atherosclerosis	0.00117	0.00149	CcSEcCtD
Cyproterone acetate—Rash—Rosuvastatin—atherosclerosis	0.00117	0.00149	CcSEcCtD
Cyproterone acetate—Dermatitis—Rosuvastatin—atherosclerosis	0.00117	0.00148	CcSEcCtD
Cyproterone acetate—Urticaria—Simvastatin—atherosclerosis	0.00116	0.00148	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Niacin—atherosclerosis	0.00116	0.00148	CcSEcCtD
Cyproterone acetate—Body temperature increased—Simvastatin—atherosclerosis	0.00116	0.00148	CcSEcCtD
Cyproterone acetate—Abdominal pain—Simvastatin—atherosclerosis	0.00116	0.00148	CcSEcCtD
Cyproterone acetate—Headache—Rosuvastatin—atherosclerosis	0.00116	0.00148	CcSEcCtD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—atherosclerosis	0.00116	0.00572	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Lovastatin—atherosclerosis	0.00116	0.00147	CcSEcCtD
Cyproterone acetate—Decreased appetite—Pravastatin—atherosclerosis	0.00115	0.00147	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—IL10—atherosclerosis	0.00115	0.00569	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—PPARG—atherosclerosis	0.00115	0.00567	CbGpPWpGaD
Cyproterone acetate—Fatigue—Pravastatin—atherosclerosis	0.00114	0.00146	CcSEcCtD
Cyproterone acetate—Constipation—Pravastatin—atherosclerosis	0.00113	0.00144	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Ezetimibe—atherosclerosis	0.00113	0.00144	CcSEcCtD
Cyproterone acetate—Asthenia—Lovastatin—atherosclerosis	0.00112	0.00143	CcSEcCtD
Cyproterone acetate—AR—penis—atherosclerosis	0.00112	0.401	CbGeAlD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AHR—atherosclerosis	0.00111	0.00551	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—SIRT1—atherosclerosis	0.00111	0.0055	CbGpPWpGaD
Cyproterone acetate—Pruritus—Lovastatin—atherosclerosis	0.00111	0.00141	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—AHR—atherosclerosis	0.00111	0.00547	CbGpPWpGaD
Cyproterone acetate—Asthenia—Ezetimibe—atherosclerosis	0.0011	0.00141	CcSEcCtD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—atherosclerosis	0.0011	0.00546	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Niacin—atherosclerosis	0.0011	0.0014	CcSEcCtD
Cyproterone acetate—Nausea—Rosuvastatin—atherosclerosis	0.0011	0.0014	CcSEcCtD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—PPARA—atherosclerosis	0.0011	0.00542	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Pravastatin—atherosclerosis	0.00109	0.00139	CcSEcCtD
Cyproterone acetate—Pruritus—Ezetimibe—atherosclerosis	0.00109	0.00139	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00108	0.00138	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Simvastatin—atherosclerosis	0.00108	0.00138	CcSEcCtD
Cyproterone acetate—Diarrhoea—Lovastatin—atherosclerosis	0.00107	0.00137	CcSEcCtD
Cyproterone acetate—Urticaria—Niacin—atherosclerosis	0.00107	0.00136	CcSEcCtD
Cyproterone acetate—Body temperature increased—Niacin—atherosclerosis	0.00106	0.00136	CcSEcCtD
Cyproterone acetate—Abdominal pain—Niacin—atherosclerosis	0.00106	0.00136	CcSEcCtD
Cyproterone acetate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—atherosclerosis	0.00105	0.00522	CbGpPWpGaD
Cyproterone acetate—Urticaria—Pravastatin—atherosclerosis	0.00105	0.00134	CcSEcCtD
Cyproterone acetate—Asthenia—Simvastatin—atherosclerosis	0.00105	0.00134	CcSEcCtD
Cyproterone acetate—Diarrhoea—Ezetimibe—atherosclerosis	0.00105	0.00134	CcSEcCtD
Cyproterone acetate—Abdominal pain—Pravastatin—atherosclerosis	0.00105	0.00134	CcSEcCtD
Cyproterone acetate—Body temperature increased—Pravastatin—atherosclerosis	0.00105	0.00134	CcSEcCtD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—MAPK3—atherosclerosis	0.00104	0.00515	CbGpPWpGaD
Cyproterone acetate—Pruritus—Simvastatin—atherosclerosis	0.00104	0.00132	CcSEcCtD
Cyproterone acetate—Dizziness—Lovastatin—atherosclerosis	0.00104	0.00132	CcSEcCtD
Cyproterone acetate—NR3C1—Circadian Clock—PPARA—atherosclerosis	0.00103	0.0051	CbGpPWpGaD
Cyproterone acetate—Dizziness—Ezetimibe—atherosclerosis	0.00102	0.0013	CcSEcCtD
Cyproterone acetate—Diarrhoea—Simvastatin—atherosclerosis	0.001	0.00128	CcSEcCtD
Cyproterone acetate—CYP19A1—FSH signaling pathway—MAPK3—atherosclerosis	0.001	0.00495	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—atherosclerosis	0.000999	0.00494	CbGpPWpGaD
Cyproterone acetate—Vomiting—Lovastatin—atherosclerosis	0.000997	0.00127	CcSEcCtD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—ESR1—atherosclerosis	0.000992	0.00491	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Niacin—atherosclerosis	0.000992	0.00126	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—EDN1—atherosclerosis	0.000992	0.00491	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	0.00099	0.00489	CbGpPWpGaD
Cyproterone acetate—Rash—Lovastatin—atherosclerosis	0.000988	0.00126	CcSEcCtD
Cyproterone acetate—Dermatitis—Lovastatin—atherosclerosis	0.000988	0.00126	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HSPD1—atherosclerosis	0.000983	0.00486	CbGpPWpGaD
Cyproterone acetate—Headache—Lovastatin—atherosclerosis	0.000982	0.00125	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—HMGCR—atherosclerosis	0.000981	0.00485	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL10—atherosclerosis	0.000981	0.00485	CbGpPWpGaD
Cyproterone acetate—Vomiting—Ezetimibe—atherosclerosis	0.000978	0.00125	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Pravastatin—atherosclerosis	0.000977	0.00124	CcSEcCtD
Cyproterone acetate—Dizziness—Simvastatin—atherosclerosis	0.00097	0.00124	CcSEcCtD
Cyproterone acetate—Rash—Ezetimibe—atherosclerosis	0.00097	0.00124	CcSEcCtD
Cyproterone acetate—Dermatitis—Ezetimibe—atherosclerosis	0.000969	0.00123	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—NAMPT—atherosclerosis	0.000967	0.00478	CbGpPWpGaD
Cyproterone acetate—Asthenia—Niacin—atherosclerosis	0.000966	0.00123	CcSEcCtD
Cyproterone acetate—Headache—Ezetimibe—atherosclerosis	0.000963	0.00123	CcSEcCtD
Cyproterone acetate—Pruritus—Niacin—atherosclerosis	0.000953	0.00121	CcSEcCtD
Cyproterone acetate—Asthenia—Pravastatin—atherosclerosis	0.000951	0.00121	CcSEcCtD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—TNF—atherosclerosis	0.000942	0.00466	CbGpPWpGaD
Cyproterone acetate—Pruritus—Pravastatin—atherosclerosis	0.000938	0.00119	CcSEcCtD
Cyproterone acetate—Vomiting—Simvastatin—atherosclerosis	0.000932	0.00119	CcSEcCtD
Cyproterone acetate—Nausea—Lovastatin—atherosclerosis	0.000931	0.00119	CcSEcCtD
Cyproterone acetate—Rash—Simvastatin—atherosclerosis	0.000925	0.00118	CcSEcCtD
Cyproterone acetate—Dermatitis—Simvastatin—atherosclerosis	0.000924	0.00118	CcSEcCtD
Cyproterone acetate—Diarrhoea—Niacin—atherosclerosis	0.000921	0.00117	CcSEcCtD
Cyproterone acetate—Headache—Simvastatin—atherosclerosis	0.000919	0.00117	CcSEcCtD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—atherosclerosis	0.000916	0.00453	CbGpPWpGaD
Cyproterone acetate—Nausea—Ezetimibe—atherosclerosis	0.000913	0.00116	CcSEcCtD
Cyproterone acetate—Diarrhoea—Pravastatin—atherosclerosis	0.000907	0.00116	CcSEcCtD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—PPARG—atherosclerosis	0.000905	0.00448	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—atherosclerosis	0.000903	0.00447	CbGpPWpGaD
Cyproterone acetate—Dizziness—Niacin—atherosclerosis	0.00089	0.00113	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—ESR2—atherosclerosis	0.000882	0.00436	CbGpPWpGaD
Cyproterone acetate—Dizziness—Pravastatin—atherosclerosis	0.000877	0.00112	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—atherosclerosis	0.000873	0.00432	CbGpPWpGaD
Cyproterone acetate—Nausea—Simvastatin—atherosclerosis	0.000871	0.00111	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CAV1—atherosclerosis	0.000869	0.0043	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.000863	0.00427	CbGpPWpGaD
Cyproterone acetate—Vomiting—Niacin—atherosclerosis	0.000856	0.00109	CcSEcCtD
Cyproterone acetate—Rash—Niacin—atherosclerosis	0.000849	0.00108	CcSEcCtD
Cyproterone acetate—Dermatitis—Niacin—atherosclerosis	0.000848	0.00108	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—HMGCR—atherosclerosis	0.000844	0.00417	CbGpPWpGaD
Cyproterone acetate—Headache—Niacin—atherosclerosis	0.000844	0.00107	CcSEcCtD
Cyproterone acetate—Vomiting—Pravastatin—atherosclerosis	0.000843	0.00107	CcSEcCtD
Cyproterone acetate—Rash—Pravastatin—atherosclerosis	0.000836	0.00106	CcSEcCtD
Cyproterone acetate—Dermatitis—Pravastatin—atherosclerosis	0.000835	0.00106	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MMP1—atherosclerosis	0.000834	0.00412	CbGpPWpGaD
Cyproterone acetate—Headache—Pravastatin—atherosclerosis	0.000831	0.00106	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—AGT—atherosclerosis	0.000823	0.00407	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.000811	0.00401	CbGpPWpGaD
Cyproterone acetate—Nausea—Niacin—atherosclerosis	0.0008	0.00102	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—ADIPOQ—atherosclerosis	0.000792	0.00392	CbGpPWpGaD
Cyproterone acetate—Nausea—Pravastatin—atherosclerosis	0.000787	0.001	CcSEcCtD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—STAT3—atherosclerosis	0.000782	0.00387	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—MAPK8—atherosclerosis	0.000777	0.00384	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—ESR1—atherosclerosis	0.00077	0.00381	CbGpPWpGaD
Cyproterone acetate—NR3C1—Circadian Clock—SERPINE1—atherosclerosis	0.000768	0.0038	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—atherosclerosis	0.000764	0.00378	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—IL6—atherosclerosis	0.00076	0.00376	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.00075	0.00371	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—atherosclerosis	0.000742	0.00367	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MMP1—atherosclerosis	0.000735	0.00363	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—SIRT1—atherosclerosis	0.000729	0.0036	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000703	0.00348	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000703	0.00348	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—AKT1—atherosclerosis	0.000703	0.00348	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—atherosclerosis	0.000685	0.00339	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL10—atherosclerosis	0.000681	0.00337	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CCL2—atherosclerosis	0.000678	0.00335	CbGpPWpGaD
Cyproterone acetate—CYP19A1—FSH signaling pathway—AKT1—atherosclerosis	0.000675	0.00334	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—ESR2—atherosclerosis	0.000669	0.00331	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—atherosclerosis	0.000668	0.0033	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—SOCS3—atherosclerosis	0.000658	0.00326	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—atherosclerosis	0.000635	0.00314	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—atherosclerosis	0.000627	0.0031	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.000604	0.00299	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MMP1—atherosclerosis	0.000594	0.00294	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—MAPK8—atherosclerosis	0.000589	0.00291	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—LPL—atherosclerosis	0.000587	0.0029	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IFNG—atherosclerosis	0.000577	0.00285	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—atherosclerosis	0.000574	0.00284	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—atherosclerosis	0.000563	0.00279	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000556	0.00275	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—ESR1—atherosclerosis	0.000549	0.00271	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—GSTM1—atherosclerosis	0.000542	0.00268	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.000538	0.00266	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CXCL8—atherosclerosis	0.000536	0.00265	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—GSTM1—atherosclerosis	0.000534	0.00264	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000523	0.00258	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000523	0.00258	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—PPARA—atherosclerosis	0.000518	0.00256	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL10—atherosclerosis	0.000516	0.00255	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000513	0.00254	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MMP1—atherosclerosis	0.000511	0.00253	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—atherosclerosis	0.000508	0.00251	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000504	0.00249	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—AGT—atherosclerosis	0.000502	0.00248	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—LEP—atherosclerosis	0.000492	0.00243	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MMP9—atherosclerosis	0.000485	0.0024	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—atherosclerosis	0.000472	0.00234	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—ESR1—atherosclerosis	0.000472	0.00234	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—STAT3—atherosclerosis	0.000469	0.00232	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000466	0.0023	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.000455	0.00225	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000442	0.00218	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000442	0.00218	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000442	0.00218	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000442	0.00218	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000436	0.00216	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—PPARG—atherosclerosis	0.000428	0.00212	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—atherosclerosis	0.000423	0.00209	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000421	0.00208	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—INS—atherosclerosis	0.00042	0.00208	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—atherosclerosis	0.000416	0.00206	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—TGFB1—atherosclerosis	0.000409	0.00202	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—AKT1—atherosclerosis	0.000409	0.00202	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IGF1—atherosclerosis	0.000406	0.00201	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.000404	0.002	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—atherosclerosis	0.000403	0.00199	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TGFB1—atherosclerosis	0.0004	0.00198	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.000394	0.00195	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—PARP1—atherosclerosis	0.000393	0.00195	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000389	0.00192	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—SERPINE1—atherosclerosis	0.000386	0.00191	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—LDLRAP1—atherosclerosis	0.000384	0.0019	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000375	0.00186	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—ESR2—atherosclerosis	0.000373	0.00184	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.000372	0.00184	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—atherosclerosis	0.000363	0.0018	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PLTP—atherosclerosis	0.000361	0.00179	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.000357	0.00177	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—NFKB1—atherosclerosis	0.000342	0.00169	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000335	0.00166	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000333	0.00165	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000333	0.00164	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000331	0.00163	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	0.000326	0.00161	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	0.000326	0.00161	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.000323	0.0016	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCG8—atherosclerosis	0.000313	0.00155	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—LTA4H—atherosclerosis	0.000313	0.00155	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—atherosclerosis	0.00031	0.00153	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000309	0.00153	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.000302	0.0015	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—AKT1—atherosclerosis	0.000302	0.00149	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL6—atherosclerosis	0.000301	0.00149	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PARP1—atherosclerosis	0.000298	0.00148	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—atherosclerosis	0.000294	0.00146	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000292	0.00144	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	0.000283	0.0014	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—ESR2—atherosclerosis	0.000283	0.0014	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.000282	0.0014	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	0.000278	0.00138	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.000271	0.00134	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—atherosclerosis	0.000267	0.00132	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—atherosclerosis	0.000265	0.00131	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—STAT3—atherosclerosis	0.000263	0.0013	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.00026	0.00129	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.000259	0.00128	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	0.000257	0.00127	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000253	0.00125	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—PPARA—atherosclerosis	0.000249	0.00123	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCG1—atherosclerosis	0.000248	0.00122	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	0.000247	0.00122	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—atherosclerosis	0.000245	0.00121	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TGFB1—atherosclerosis	0.000244	0.0012	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	0.000243	0.0012	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	0.000236	0.00117	CbGpPWpGaD
Cyproterone acetate—CYP19A1—connective tissue—atherosclerosis	0.000234	0.0838	CbGeAlD
Cyproterone acetate—CYP19A1—Metabolism—LCAT—atherosclerosis	0.000233	0.00115	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—FABP4—atherosclerosis	0.000233	0.00115	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.000229	0.00113	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOA4—atherosclerosis	0.000228	0.00113	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TNF—atherosclerosis	0.000227	0.00112	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—ESR1—atherosclerosis	0.000226	0.00112	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP7A1—atherosclerosis	0.000224	0.00111	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	0.00022	0.00109	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000214	0.00106	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HSPA1B—atherosclerosis	0.000212	0.00105	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.000209	0.00103	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP27A1—atherosclerosis	0.000207	0.00103	CbGpPWpGaD
Cyproterone acetate—AR—connective tissue—atherosclerosis	0.000207	0.0742	CbGeAlD
Cyproterone acetate—AR—Generic Transcription Pathway—PPARG—atherosclerosis	0.000206	0.00102	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000204	0.00101	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.000199	0.000985	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—AKT1—atherosclerosis	0.000198	0.000979	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALOX5AP—atherosclerosis	0.000197	0.000973	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOA2—atherosclerosis	0.000197	0.000973	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PLA2G2A—atherosclerosis	0.000197	0.000973	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALOX15—atherosclerosis	0.000197	0.000973	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.000197	0.000972	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCG5—atherosclerosis	0.000194	0.000961	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000194	0.00096	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PARP1—atherosclerosis	0.000189	0.000937	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PPARA—atherosclerosis	0.000189	0.000936	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—LPA—atherosclerosis	0.000188	0.000928	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—SERPINE1—atherosclerosis	0.000186	0.000918	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IL6—atherosclerosis	0.000184	0.000908	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—BGN—atherosclerosis	0.000182	0.000899	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.00018	0.000892	CbGpPWpGaD
Cyproterone acetate—AR—cardiovascular system—atherosclerosis	0.00018	0.0645	CbGeAlD
Cyproterone acetate—CYP19A1—Metabolism—APOA5—atherosclerosis	0.00018	0.00089	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ESR2—atherosclerosis	0.000179	0.000887	CbGpPWpGaD
Cyproterone acetate—CYP19A1—adipose tissue—atherosclerosis	0.000179	0.0643	CbGeAlD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000175	0.000864	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PLA2G1B—atherosclerosis	0.000173	0.000856	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—ESR1—atherosclerosis	0.000171	0.000848	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000171	0.000847	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—atherosclerosis	0.00017	0.000843	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.00017	0.000839	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000169	0.000837	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALOX5—atherosclerosis	0.000167	0.000827	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	0.000164	0.000811	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HSPA1B—atherosclerosis	0.000161	0.000797	CbGpPWpGaD
Cyproterone acetate—AR—adipose tissue—atherosclerosis	0.000159	0.0569	CbGeAlD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.000159	0.000785	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PPARG—atherosclerosis	0.000156	0.000773	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000154	0.000764	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NAMPT—atherosclerosis	0.00015	0.000742	CbGpPWpGaD
Cyproterone acetate—NR3C1—connective tissue—atherosclerosis	0.00015	0.0537	CbGeAlD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000149	0.000737	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—LIPC—atherosclerosis	0.000149	0.000737	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOC3—atherosclerosis	0.000148	0.000733	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—LDLR—atherosclerosis	0.000147	0.000728	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—SIRT1—atherosclerosis	0.000144	0.000714	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CETP—atherosclerosis	0.000144	0.000711	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PARP1—atherosclerosis	0.000144	0.000711	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—SERPINE1—atherosclerosis	0.000141	0.000697	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SCARB1—atherosclerosis	0.000138	0.000681	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ESR2—atherosclerosis	0.000136	0.000673	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000134	0.000663	CbGpPWpGaD
Cyproterone acetate—NR3C1—cardiovascular system—atherosclerosis	0.00013	0.0467	CbGeAlD
Cyproterone acetate—CYP19A1—Metabolism—HMGCR—atherosclerosis	0.00013	0.000643	CbGpPWpGaD
Cyproterone acetate—CYP19A1—liver—atherosclerosis	0.000126	0.0451	CbGeAlD
Cyproterone acetate—AR—Gene Expression—PPARA—atherosclerosis	0.00012	0.000594	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000117	0.00058	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCA1—atherosclerosis	0.000116	0.000573	CbGpPWpGaD
Cyproterone acetate—NR3C1—adipose tissue—atherosclerosis	0.000115	0.0412	CbGeAlD
Cyproterone acetate—AR—liver—atherosclerosis	0.000111	0.0399	CbGeAlD
Cyproterone acetate—NR3C1—Gene Expression—SIRT1—atherosclerosis	0.00011	0.000542	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ESR1—atherosclerosis	0.000109	0.000538	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HMOX1—atherosclerosis	9.94e-05	0.000492	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PPARG—atherosclerosis	9.92e-05	0.000491	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOB—atherosclerosis	9.52e-05	0.000471	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTM1—atherosclerosis	9.27e-05	0.000458	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PPARA—atherosclerosis	9.11e-05	0.000451	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—LPL—atherosclerosis	9.09e-05	0.00045	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—SERPINE1—atherosclerosis	8.94e-05	0.000442	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GPX1—atherosclerosis	8.87e-05	0.000439	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CD36—atherosclerosis	8.64e-05	0.000427	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ESR1—atherosclerosis	8.25e-05	0.000408	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MTHFR—atherosclerosis	8.19e-05	0.000405	CbGpPWpGaD
Cyproterone acetate—NR3C1—liver—atherosclerosis	8.06e-05	0.0289	CbGeAlD
Cyproterone acetate—CYP19A1—Metabolism—PPARA—atherosclerosis	8.03e-05	0.000397	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AGT—atherosclerosis	7.78e-05	0.000385	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOE—atherosclerosis	7.62e-05	0.000377	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CAV1—atherosclerosis	7.55e-05	0.000374	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOA1—atherosclerosis	7.54e-05	0.000373	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PPARG—atherosclerosis	7.53e-05	0.000372	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CG—atherosclerosis	6.88e-05	0.00034	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SERPINE1—atherosclerosis	6.78e-05	0.000335	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPARG—atherosclerosis	6.64e-05	0.000328	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—INS—atherosclerosis	6.51e-05	0.000322	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALB—atherosclerosis	5.97e-05	0.000295	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MAPK3—atherosclerosis	5.82e-05	0.000288	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NOS3—atherosclerosis	5.71e-05	0.000282	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS2—atherosclerosis	5.22e-05	0.000258	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MAPK3—atherosclerosis	4.41e-05	0.000218	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—AKT1—atherosclerosis	3.92e-05	0.000194	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AKT1—atherosclerosis	2.98e-05	0.000147	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKT1—atherosclerosis	2.63e-05	0.00013	CbGpPWpGaD
